Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Marjanovic, Marija M (56437423000)"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Impact on long-term mortality of access and non-access site bleeding after primary percutaneous coronary intervention
    (2019)
    Matic, Dragan M (25959220100)
    ;
    Asanin, Milika R (8603366900)
    ;
    Vukcevic, Vladan D (15741934700)
    ;
    Mehmedbegovic, Zlatko H (55778381000)
    ;
    Marinkovic, Jelena M (7004611210)
    ;
    Kocev, Nikola I (6602672952)
    ;
    Marjanovic, Marija M (56437423000)
    ;
    Mrdovic, Igor B (10140828000)
    ;
    Antonijevic, Nebojsa M (6602303948)
    ;
    Milosevic, Aleksandra D (56622640900)
    ;
    Zivkovic, Milorad N (55959530600)
    ;
    Krljanac, Gordana V (8947929900)
    ;
    Stankovic, Sanja Dj (7005216636)
    ;
    Milasinovic, Dejan G (24823024500)
    ;
    Lasica, Ratko M (14631892300)
    ;
    Stankovic, Goran R (59150945500)
    Objectives The influence of the bleeding site on long-term survival after the primary percutaneous coronary intervention (PCI) is poorly understood. This study sought to investigate the relationship between in-hospital access site versus non-access site bleeding and very late mortality in unselected patients treated with primary PCI. Methods Data of the 2715 consecutive patients with ST-segment elevation myocardial infarction treated with primary PCI, enrolled in a prospective registry of a high volume tertiary centre, were analysed. Bleeding events were assessed according to the Bleeding Academic Research Consortium (BARC) criteria. The primary outcome was 4-year mortality. Results The BARC type ≥2 bleeding occurred in 171 patients (6.3%). Access site bleeding occurred in 3.8%, and non-access site bleeding in 2.5% of patients. Four-year mortality was significantly higher for patients with bleeding (BARC type ≥2) than in patients without bleeding (BARC type 0+1), (36.3% vs 16.2%, p<0.001). Patients with non-access site bleeding had higher 4 year mortality (50.7% vs 26.5%, p=0.001). After multivariable adjustment, BARC type ≥2 bleeding was the independent predictor of 4 year mortality (HR 2.01; 95% CI 1.49 to 2.71, p<0.001). Patients with a non-access site bleeding were at 2-fold higher risk of very late mortality than patients with an access site bleeding (HR 2.62; 1.78 to 3.86, p<0.001 vs HR 1.57; 1.03 to 2.38, p=0.034). Conclusions Both access and non-access site BARC type ≥2 bleeding is independently associated with a high risk of 4-year mortality after primary PCI. Patients with non-access site bleeding were at higher risk of late mortality than patients with access site bleeding. © 2019 Author(s) (or their employer(s)).

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback